Xianwu Zeng Selected Research

poly(N-(2-hydroxypropyl methacrylamide)- co- sulfapyridine- co- diethylenetriaminepentaacetic acid)

1/2013

Passive and active hepatoma tumor targeting of new N-(2-hydroxypropyl)methacrylamide copolymer conjugates: synthesis, characterization, and evaluation in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xianwu Zeng Research Topics

Disease

3	Neoplasms (Cancer) 01/2020 - 01/2013
2	Japanese Encephalitis 01/2018 - 10/2014
2	Carcinoma (Carcinomatosis) 01/2013 - 01/2013
1	Dengue (Dengue Fever) 10/2014
1	Necrosis 01/2013
1	Lung Neoplasms (Lung Cancer) 01/2013
1	Hepatocellular Carcinoma (Hepatoma) 01/2013
1	Infections 04/2009

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 01/2018 - 01/2013
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020
1	imidazoleIBA 01/2020
1	Pentetic Acid (DTPA)FDA LinkGeneric 01/2020
1	MicellesIBA 01/2020
1	PolymersIBA 01/2020
1	Dengue VaccinesIBA 10/2014
1	Complementary DNA (cDNA)IBA 10/2014
1	Japanese Encephalitis VaccinesIBA 10/2014
1	Measles VaccineIBA 01/2013
1	poly(N-(2-hydroxypropyl methacrylamide)- co- sulfapyridine- co- diethylenetriaminepentaacetic acid)IBA 01/2013
1	MV-ONEIBA 01/2013
1	N-(2-hydroxypropyl)methacrylamideIBA 01/2013
1	RNA (Ribonucleic Acid)IBA 04/2009

Therapy/Procedure

1	Quantum Dots (Quantum Dot) 01/2020
1	Photochemotherapy (Photodynamic Therapy) 01/2020
1	Therapeutics 01/2013